|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-4-3
|
|
pubmed:abstractText |
In rectal cancer altered expression of p53 or DCC may be indicative of poor patient prognosis. This study determined by immunohistochemistry the tumour status of p53 protein and DCC protein in patients with rectal cancer who had a curative resection and were followed-up prospectively and examined the correlation to clinical and pathology variables.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0179-1958
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
188-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12673482-Cell Adhesion Molecules,
pubmed-meshheading:12673482-Female,
pubmed-meshheading:12673482-Follow-Up Studies,
pubmed-meshheading:12673482-Humans,
pubmed-meshheading:12673482-Immunohistochemistry,
pubmed-meshheading:12673482-Male,
pubmed-meshheading:12673482-Neoplasm Recurrence, Local,
pubmed-meshheading:12673482-Prospective Studies,
pubmed-meshheading:12673482-Receptors, Cell Surface,
pubmed-meshheading:12673482-Rectal Neoplasms,
pubmed-meshheading:12673482-Survival Analysis,
pubmed-meshheading:12673482-Tumor Suppressor Protein p53,
pubmed-meshheading:12673482-Tumor Suppressor Proteins
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
p53 and DCC immunohistochemistry in curative rectal cancer surgery.
|
|
pubmed:affiliation |
University of Sydney Surgical Outcomes Research Centre and Department of Colorectal Surgery, Royal Prince Alfred and Concord Hospitals, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
